Audio file not found.
Akihiro Kobayashi, president of Kobayashi Pharmaceutical Co., arrives at a news conference in Osaka, western Japan, Friday, March 29, 2024. In the week since a line of Japanese health supplements began being recalled, several people have died and more than 100 people were hospitalized as of Friday. The Osaka-based pharmaceutical company came under fire for not going public quickly with problems known internally as early as January. The first public announcement came March 22. (Yohei Fukuyama/Kyodo News via AP)
A factory of Kobayashi Pharmaceutical Co., is seen in Osaka, Japan on March 26, 2024. Health supplement products believed to have caused a few deaths and sickened more than a hundred people have been ordered taken off store shelves in Japan. The products from Kobayashi Pharmaceutical, billed as helping lower cholesterol, contained an ingredient called “benikoji,” a red species of mold.(Keiji Uesho/Kyodo News via AP)
Akihiro Kobayashi, president of Kobayashi Pharmaceutical Co., bows in apology at a news conference in Osaka, western Japan, Friday, March 29, 2024. In the week since a line of Japanese health supplements began being recalled, several people have died and more than 100 people were hospitalized as of Friday. The Osaka-based pharmaceutical company came under fire for not going public quickly with problems known internally as early as January. The first public announcement came March 22. (Kyodo News via AP)
Akihiro Kobayashi, president of Kobayashi Pharmaceutical Co., arrives at a news conference in Osaka, western Japan, Friday, March 29, 2024. In the week since a line of Japanese health supplements began being recalled, several people have died and more than 100 people were hospitalized as of Friday. The Osaka-based pharmaceutical company came under fire for not going public quickly with problems known internally as early as January. The first public announcement came March 22. (Yohei Fukuyama/Kyodo News via AP)